Select a Region

North America

Newscenter

Read our latest news!

EVERSANA

Posted on September 19, 20239/19/23

Sy Pretorius, EVERSANA Chief Operating Officer, Named to Prestigious PharmaVoice 100 List for 2023

EVERSANA

Posted on September 18, 20239/18/23

EVERSANA Unveils ACTICS eAccess, New Technology-Enabled eBV and ePA Patient Support Platform to Improve Patient Access and Accelerate Speed to Therapy

EVERSANA

Posted on September 6, 20239/6/23

EVERSANA Names Ryan Sparks Chief Information Officer

EVERSANA

Posted on August 30, 20238/30/23

EVERSANA Unveils EVERSANA ORCHESTRATE, Life Science Industry’s First End-to-End Omnichannel Solution Driving Brand Connectivity and Activating Commercialization Services

EVERSANA

Posted on July 25, 20237/25/23

Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting

EVERSANA

Posted on July 24, 20237/24/23

EVERSANA & Amazon Web Services to “Pharmatize” Artificial Intelligence across the Life Sciences Industry

EVERSANA

Posted on June 26, 20236/26/23

EVERSANA INTOUCH Wins Gold at Cannes Lions International Festival of Creativity

EVERSANA

Posted on June 5, 20236/5/23

EVERSANA INTOUCH Wins Five Clio Awards

EVERSANA

Posted on June 1, 20236/1/23

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

Posted on May 25, 20235/25/23

Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes